STOCK TITAN

Electromed, Inc. to Participate in Noble Capital Markets' 21st Annual Emerging Growth Equity Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Electromed (NYSE American: ELMD) will present at NobleCon21, Noble Capital Markets' 21st Annual Emerging Growth Equity Conference, on Wednesday, December 3, 2025 at Florida Atlantic University in Boca Raton, Florida.

Jim Cunniff, Electromed's President and Chief Executive Officer, will present at 5:00 PM ET. A video webcast of the presentation will be available the following day on Electromed's Events & Presentations page and on the Noble Capital Markets conference catalog at www.nobleconference.com.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+3.23% News Effect

On the day this news was published, ELMD gained 3.23%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

New Prague, Minnesota--(Newsfile Corp. - November 20, 2025) - Electromed, Inc. (NYSE American: ELMD) ("Electromed" or the "Company"), a leader in innovative airway clearance technologies, today announced that it will participate in NobleCon21 - Noble Capital Markets' Twenty First Annual Emerging Growth Equity Conference being held at Florida Atlantic University in Boca Raton, Florida, on Wednesday, December 3, 2025. Jim Cunniff, Electromed's President and Chief Executive Officer, will present at 5:00 pm ET.

A video webcast of the presentation will be available the following day on Electromed's website Events & Presentations, and as part of a complete catalog of presentations available at Noble Capital Markets' Conference website: www.nobleconference.com.

About Electromed, Inc.

Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, Minnesota, and was founded in 1992. Further information about Electromed can be found at www.smartvest.com.

About Noble Capital Markets, Inc.

Established in 1984, Noble Capital Markets (Noble) is an SEC / FINRA registered full-service broker-dealer offering investment/merchant banking and advisory services, with an award-winning research team, and a proprietary research distribution platform (Channelchek). Noble provides middle-market expertise to entrepreneurs, corporations, financial sponsors, and investors. In addition to its large scale in-person conference, NobleCon, Noble hosts multi-sector virtual conferences throughout the year. Over the more than 40 years, Noble has raised billions of dollars for companies and published more than 45,000 equity research reports. www.noblecapitalmarkets.com | www.nobleconference.com.

Brad Nagel, Chief Financial Officer
(952) 758-9299
investorrelations@electromed.com

Mike Cavanaugh, Investor Relations
ICR Healthcare
(617) 877-9641
mike.cavanaugh@icrhealthcare.com

Source: Electromed, Inc.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/275255

FAQ

When will Electromed (ELMD) present at NobleCon21?

Electromed will present on December 3, 2025 at 5:00 PM ET.

Who will present for Electromed (ELMD) at the Noble Capital Markets conference?

Jim Cunniff, Electromed's President and Chief Executive Officer, will present.

How can investors watch Electromed's (ELMD) NobleCon21 presentation?

A video webcast will be posted the day after the presentation on Electromed's Events & Presentations page and on www.nobleconference.com.

What is NobleCon21 and where is it held for Electromed's (ELMD) presentation?

NobleCon21 is Noble Capital Markets' 21st Annual Emerging Growth Equity Conference at Florida Atlantic University, Boca Raton, Florida.

Will Electromed (ELMD) provide slides or a replay of the NobleCon21 presentation?

Yes. A video webcast and the conference presentation catalog will be available online the day after the event.
Electromed

NYSE:ELMD

ELMD Rankings

ELMD Latest News

ELMD Latest SEC Filings

ELMD Stock Data

235.54M
6.56M
21.3%
53.31%
3.37%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
NEW PRAGUE